Announced Fri, 14 Aug · 13:07 IST
Parmax Pharma: Acquirer group buys 11.52 lakh shares, stake crosses 50 percent
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹115.45
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+4.0+6.1+8.2+10.4+12.5—————
Up moveDown movePending
AI summary
Acquirers and PACs purchased 11,52,450 equity shares of Parmax Pharma at Rs 35 per share on Aug 13, 2026, via a Share Purchase Agreement dated June 8, 2026. Combined shareholding rose from 27.20 percent to 58.01 percent, crossing the majority threshold. Acquirer 1 Dhiren Shah holds 12.49 percent, Acquirer 2 Sunil Shah holds 1.90 percent post deal.
Likely market impact
Change of control at Parmax Pharma; acquirer group now holds 58.01 percent, taking majority ownership via off-market deal.